Patents by Inventor Ingrid Nilsson

Ingrid Nilsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10961304
    Abstract: A method of reducing an effect of stroke in a subject, the method comprising administering to the subject a compound that inhibits VEGF-B signaling.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: March 30, 2021
    Assignees: CSL Limited, B-Creative Sweden AB
    Inventors: Ulf Eriksson, Ingrid Nilsson, Daniel Lawrence, Enming Joe Su
  • Publication number: 20190315849
    Abstract: A method of reducing an effect of stroke in a subject, the method comprising administering to the subject a compound that inhibits VEGF-B signaling.
    Type: Application
    Filed: May 14, 2019
    Publication date: October 17, 2019
    Applicants: CSL Limited, B-Creative Sweden AB
    Inventors: Ulf ERIKSSON, Ingrid NILSSON, Daniel LAWRENCE, Enming Joe SU
  • Patent number: 10336821
    Abstract: A method of reducing an effect of stroke in a subject, the method comprising administering to the subject a compound that inhibits VEGF-B signaling.
    Type: Grant
    Filed: November 17, 2015
    Date of Patent: July 2, 2019
    Assignees: CSL Limited, B-Creative Sweden AB
    Inventors: Ulf Eriksson, Ingrid Nilsson, Daniel Lawrence, Enming Joe Su
  • Publication number: 20180237513
    Abstract: A method of reducing an effect of stroke in a subject, the method comprising administering to the subject a compound that inhibits VEGF-B signaling
    Type: Application
    Filed: November 17, 2015
    Publication date: August 23, 2018
    Applicants: CSL Limited, B-Creative Sweden AB
    Inventors: Ulf ERIKSSON, Ingrid NILSSON, Daniel LAWRENCE, Enming Joe SU
  • Publication number: 20040115767
    Abstract: A method of identifying immunogenic Helicobacter pylori-specific surface proteins binding specifically to polysulphated molecules, is described. Further, a Helicobacter pylori-specific surface protein product, and a protein contained therein, binding specifically to polysulphated molecules are disclosed. Examples of such proteins are a protein having a MW of 30 (31.3) kDa, a (pI) of 9.3 (9.1) and comprising SEQ ID NO: 1 and/or SEQ ID NO: 2; a protein having a MW of 26 (27.7), a pI of 9.1-9.3 (9.0) and comprising SEQ ID NO: 4; or a protein having a MW of 25 (28.7), a pI of 9.0 (8.8) and comprising SEQ ID NO: 5. Additionally, use of a protein or protein product of the invention as a diagnostic antigen and as a component in a vaccine against H. pylori infection, as well as an immunoassay and a vaccine composition against a H. pylori infection, are described.
    Type: Application
    Filed: February 4, 2004
    Publication date: June 17, 2004
    Inventors: Asa Ljungh, Ingrid Nilsson, Meeme Utt, Torkel Wadstrom